Botulism immune globulin

Drug Profile

Botulism immune globulin

Alternative Names: BabyBIG; BIG-IV; Botulinum toxin immune globulin; Botulism immune globulin intravenous (human); Botulism IVIG; Human-derived botulinum antitoxin; IV botulism immune globulin

Latest Information Update: 06 Apr 2004

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator California Department of Health Services
  • Class Immunoglobulins
  • Mechanism of Action Botulinum toxin inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Botulism

Highest Development Phases

  • Marketed Botulism

Most Recent Events

  • 31 Dec 2003 Launched for Botulism in USA (IV)
  • 23 Oct 2003 Registered for Botulism in USA (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top